Viewing data from:

CYCLOMYDRIL

ANDA

CYCLOPENTOLATE HYDROCHLORIDE; PHENYLEPHRINE HYDROCHLORIDE | A084300 | ALCON LABORATORIES INC

1 strength0 unique patents0 unique exclusivities

Medicare Part D Spending

CMS annual spending data for Cyclomydril (2023)

Total Spending

$744.60

Total Claims

Beneficiaries

Avg Cost/Unit

$23.27

Spending Trend

$623.95(2019)→$638.33(2021)→$744.60(2023)

5yr CAGR:+2.9%

Source: CMS Medicare Part D Spending by Drug (2023). Shows gross drug cost under Part D.

Products (1)

#001 — 0.2%;1%

RLD

0 patents0 exclusivities▴

SOLUTION/DROPS;OPHTHALMIC | Approved: Approved Prior to Jan 1, 1982

No patent or exclusivity listings for this strength.